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نازعة هيدروجني الالكتات وبيتا غلوكورونيداز كوامسات لعاب حيوية كيميائية يف 
التهاب دواعم السن عند املدخنني وغري املدخنني
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abstract: Objectives: This study aimed to establish lactate dehydrogenase (LDH) and β-glucuronidase as salivary 
biomarkers of periodontitis among smokers and non-smokers. Methods: This cross-sectional case-control study was 
conducted at the Aligarh Muslim University, Aligarh, India, between January and June 2017. A total of 200 participants 
were divided into four groups based on their periodontal and smoking statuses. Unstimulated mixed saliva samples 
were collected to estimate LDH and β-glucuronidase levels. In addition, total protein was estimated using Lowry’s 
method. Results: There was a significant increase in enzyme activity in the periodontitis groups compared to the non-
periodontitis groups (P <0.001). However, significantly lower enzyme activity was observed among smokers, irrespective 
of periodontal status (P <0.001). Nevertheless, a receiver operating characteristic curve analysis indicated the diagnostic 
potential of both enzymes to be fair-to-excellent. Conclusion: Although smoking was found to significantly alter enzyme 
activity, LDH and β-glucuronidase were reliable salivary biomarkers of periodontitis among both smokers and non-
smokers.
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الالكتات وبيتا غلوكورونيداز كوا�شمات لعاب حيوية كيميائية  التثبت من نازعة هيدروجني  اإىل  الدرا�شة  الهدف: تهدف هذه  امللخ�ص: 
األيجاره  جامعة  يف  املقطعية   ال�شواهد  حلالت  الدرا�شة   هذه   اأجريت  الطريقة:  املدخنني.  وغري  املدخنني  عند  ال�شن  دواعم  التهاب  يف 
الإ�شالمية، األيجاره، الهند، يف الفرتة ما بني يناير ويونيو 2017. مت تق�شيم ما جمموعه 200 م�شارك اإىل اأربع جمموعات على اأ�شا�ص حالة 
اللثة والتدخني. مت جمع عينات اللعاب املختلط وغري املحفز لتقدير م�شتويات نازعة هيدروجني الالكتات وبيتا غلوكورونيداز. بالإ�شافة 
اإىل ذلك، مت تقدير الربوتني الكلي با�شتخدام طريقة لأوري. النتائج: كان هناك زيادة معنوية يف ن�شاط الإنزمي يف جمموعات التهاب اللثة 
باملقارنة مبجموعات بدون التهاب اللثة )P >0.001(. ومع ذلك، لوحظ وجود ن�شاط اأنزمي اأقل ب�شكل ملحوظ بني املدخنني، بغ�ص النظر 
عن حالة اللثة )P >0.001(. ومع ذلك، اأ�شار حتليل منحنى خ�شائ�ص الت�شغيل املتلقي اإىل اإمكانات الت�شخي�ص لكل الإنزميات لتكون عادلة 
اإىل ممتازة. اخلال�صة: على الرغم من اأن التدخني يغري ن�شاط الإنزمي ب�شكل كبري، كانت نازعة هيدروجني الالكتات وبيتا غلوكورونيداز 
موؤ�رسات حيوية لعابية موثوقة للتهاب اللثة بني املدخنني وغري املدخنني على حد �شواء.
ا�شتخدام تدخني؛  غلوكورونيداز؛  بيتا  الالكتات؛  هيدروجني  نازعة  لعاب؛  بيولوجية؛  وا�شمات  ال�شن؛  دواعم  التهاب  املفتاحية:   الكلمات 
التبغ؛ الهند.
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Advances in Knowledge
- This study rules out the effect of tobacco smoke on the diagnostic ability of two salivary enzymes—lactate dehydrogenase (LDH) and 
β-glucuronidase—in risk profiling for periodontal disease.
Application to Patient Care
- The current findings support the use of these salivary enzymes as biomarkers for periodontal disease.
doi: 10.18295/squmj.2018.18.03.009
Periodontal disease is a common inflamm-atory disease caused by the interaction between certain Gram-negative bacterial species and 
components of the host immune response.1 Chronic 
periodontal infections trigger the release of a myriad 
of metabolic byproducts, destructive cellular enzymes 
and other mediators of tissue destruction at the inter-
face between the tooth and the periodontal pocket.2 
As a result, the normal histological architecture of the 
periodontium is disturbed, with persistent inflammation 
associated with the irreversible loss of mineralised and 
non-mineralised tissues.1
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Chronic periodontitis may advance without causing 
severe oral discomfort; as such, subjects often seek 
professional care only after the periodontal tissue is 
considerably damaged.3 Thus, there is an urgent need to 
diagnose this disease in its initial stages so as to initiate 
early intervention. Ideally, a diagnostic marker should 
be highly specific and sensitive and should indicate the 
presence of a disease process prior to the occurrence 
of extensive clinical damage.4 At present, a diagnosis of 
periodontitis is usually made via imaging and clinical 
assessment of probing pocket depth, bleeding upon 
probing and clinical attachment level.5 However, the 
utility of such measurements is limited because these 
findings may display evidence of previous rather than 
current disease activity.6 
The saliva contains a wide and unique variety of 
proteins and enzymes with important oral biological 
functions. The pathogenesis of periodontitis has been 
linked to alterations in various salivary enzymes, incl- 
uding lactate dehydrogenase (LDH), alkaline phosphatase, 
matrix metalloproteinases 8 and 1, aminotransferases, 
amylase, β-glucuronidases, arginase, chitinases and dip- 
eptidyl peptidase.7 Metabolic LDH plays a key role in 
anaerobic glycolysis and its extracellular presence is 
always related to cell necrosis and tissue breakdown.8 In 
contrast, β-glucuronidase is a neutrophil-derived lyso- 
somal acid hydrolase stored in the azurophilic granules. 
It is active in the degradation of proteoglycans and the 
ground substance and is considered a marker for azu- 
rophilic granule release by polymorphonuclear leuko-
cyte lysosomes.9 Under these considerations, salivary 
LDH and β-glucuronidase may play a potential role as 
salivary biomarkers of periodontal disease.7 
Unfortunately, the diagnostic use of these enzymes 
in periodontitis cases has been hampered as current 
understanding of the biomolecules present in saliva 
and their relevance to disease aetiology is still limited. 
In addition, various factors may cause enzymatic 
alterations, such as temperature, pH, and enzyme and 
substrate concentrations of inhibitors or activators.10 For 
example, tobacco smoke compounds have been found 
to impair salivary enzyme activities at the molecular 
level.11 Therefore, this study aimed to attempt to establish 
LDH and β-glucuronidase as salivary biochemical 
markers for periodontitis and to assess their diagnostic 
potential among both smokers and non-smokers.
Methods 
This cross-sectional case-control study was conducted at 
the Department of Periodontology of the Aligarh Muslim 
University, Aligarh, Uttar Pradesh, India, between January 
and June 2017. The required sample size was calculated 
using G*Power Software, Version 3.0.10 (Heinrich-Heine- 
Universität Düsseldorf, Düsseldorf, Germany), based on 
a calculated effect size of 0.565 as per the results of 
a pilot study involving 20 subjects, with a 5% level of 
precision, 95% confidence interval and 80% statistical 
power. The minimum sample size was calculated to 
be 200 subjects. Patients who had received antiseptic, 
professional hygiene or periodontal therapies or treat- 
ment with anti-inflammatory drugs, immunosuppress-
ants or corticosteroids in the preceding six months were 
excluded from the study. In addition, individuals under- 
going orthodontic treatment or other dental procedures, 
subjects with acute oral mucosal lesions and/or suspected 
oral malignancies, those with adverse behavioural habits 
such as tobacco/paan chewing or alcohol abuse, subjects 
suffering from any systemic diseases and pregnant, 
lactating or post-menopausal women were also excluded. 
A total of 1,306 patients aged 30–50 years old pres- 
enting to the Department of Periodontology, Dr. Ziauddin 
Ahmad Dental College & Hospital, Aligarh, Uttar Pradesh, 
were screened. A simple random sampling method was 
used to select 200 of these individuals for inclusion in 
the study. The participants were divided into four groups 
of 50 subjects each, including non-smokers with no/mild 
gingivitis, non-smokers with no/mild gingivitis, smokers 
with chronic generalised periodontitis and smokers with 
chronic generalised periodontitis [Figure 1]. Unfortunately, 
it was logistically difficult to find sufficient cases with no 
gingival inflammation; as such, cases with no/mild 
gingivitis were considered to constitute the control 
groups in the study design. Mild gingivitis was diagnosed 
based on the Silness-Löe gingival index.12 Chronic 
generalised periodontitis was defined as a probing pocket 
depth of ≥5 mm, clinical attachment loss of ≥3 mm 
and moderate, severe or generalised disease progr-
ession involving >30% of the mouth. Patients were 
categorised as smokers or non-smokers based on the 
updated definition of the Centers for Disease Control 
and Prevention.13 All smokers reported currently smoking 
at least five times per day and had a history of smoking of 
at least five years. Former smokers were not included in 
the study.
A sample of approximately 5 mL of unstimulated 
mixed saliva was aseptically collected via aspiration from 
each participant while seated in an upright position. 
The collection was performed by a single trained expert 
between 9 and 11 am, five minutes after the mouth was 
rinsed with 15 mL of water to wash out any exfoliated 
cells. Eating, drinking and smoking were restricted for 
at least two hours prior to collection. The saliva was 
collected in sterile test tubes capped with sterile tinfoil. 
The samples were transferred to a refrigerated container 
at 4 °C and then centrifuged for 10 minutes at 1,500 
revolutions per minute. Subsequently, estimations of 
LDH and β-glucuronidase activity were carried out 
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immediately by a single trained biochemist who was 
blinded to the study design. 
The biochemical analysis of LDH was performed 
following strict protocols for salivary enzyme estimation.14 
LDH was assayed following the conversion of reduced 
nicotinamide adenine dinucleotide (NADH) to oxidised 
NADH at 340 nm in the presence of sodium pyruvate. 
Briefly, 100 μL of saliva was added to a 2.8 mL reaction 
mixture consisting of 0.05 M tris buffer at a pH of 
7.4, 3.33 mM of magnesium chloride and 1.6 mM 
of sodium pyruvate. Then, 100 μL of NADH (at a 
final concentrate of 0.08 mM) was added just before 
the change in absorbance observed after 3 minutes 
using a U-2910 spectrophotometer (Hitachi High-
Technologies Corp., Tokyo, Japan).14 The results were 
expressed in IU/L. 
For the analysis of salivary β-glucuronidase, 50 μL 
of 0.9% saline solution (as the control), 50 µL of standard 
4-methylumbelliferone (Sigma-Aldrich Corp., St. Louis, 
Missouri, USA) and 50 µL of the salivary samples were 
separated in designated tubes. In each tube, 100 μL of 
methylumbelliferyl β-D-glucuronide containing 0.001% 
bovine serum albumin (BSA) was added and the contents 
were mixed and incubated at 37 °C for 15 minutes. The 
reaction was stopped with 2 mL of 0.2 M glycine buffer 
at a pH of 11.7 and containing 0.2% sodium dodecyl 
sulphate. After the solution was mixed for 60 minutes, 
the fluorescence was measured at an excitation wave-
length of 360 nm and an emission wavelength of 459 nm. 
For the standard, the fluorescence of 0.008 mM and 
0.016 mM of 4-methylumbelliferone was measured 
using an RF-5301 spectrofluorophotometer (Shimadzu 
Corp., Kyoto, Japan), as the fluorescence of 0.008 mM of 
4-methylumbelliferone is equivalent to 1 IU of β-glucur- 
onidase.15 The total protein in the saliva was estimated 
by means of Lowry’s method using BSA to derive standard 
and specific enzyme activity.16
Data were analysed using the Statistical Package 
for the Social Sciences (SPSS), Version 21.0 (IBM Corp., 
Armonk, New York, USA). Parametric tests (i.e. an 
unpaired t-test) and a one-way analysis of variance were 
used to compare the mean enzyme activities of the four 
independent groups using an F distribution, followed 
by a post-hoc Tukey’s analysis. A receiver operating char- 
acteristic (ROC) curve was used to determine the diagn- 
ostic ability of the enzymes as their discrimination 
thresholds varied. Binomial logistic regression was then 
conducted to estimate the frequency of periodontitis 
among the patients. A P value of <0.050 was considered 
statistically significant. 
This study was reviewed and approved by the 
institutional ethical committee of the Kothiwal Dental 
College & Research Centre (#KDCRC/IERB/11/2015/34). 
Written informed consent from the participants was 
obtained using a pre-designed proforma. All particip-
ation in the study was voluntary in nature.
Results
The patients ranged in age between 30–35 years old 
(mean: 32.5 years). There were very few female smokers 
(20.5%). The standard and specific enzyme activity of 
LDH and β-glucuronidase in each group is presented in 
Table 1. There was a significant increase in LDH and 
β-glucuronidase enzyme activity among participants 
with periodontitis compared to those without perio-
dontitis (P <0.001) [Table 2]. However, significantly 
lower enzyme activity was noted among the smokers, 
irrespective of periodontal status (P <0.001) [Table 3]. 
Overall, there was a 23.8% and 25% reduction in LDH 
 
Figure 1: Diagram showing the protocol and design used in the current study.
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enzyme activity among smokers with periodontitis and 
smokers with no/mild gingivitis, respectively. Similarly, 
there was a 6.8% and 18.1% reduction in β-glucuron-
idase activity, respectively.
Nevertheless, logistic modelling highlighted a strong 
linear association between LDH and β-glucuronidase 
activity and periodontitis, regardless of smoking status 
(P = 0.046 and 0.010, respectively) [Table 4]. Furthermore, 
the sensitivity and specificity of the enzymes were 
established at the 25th, 50th and 75th quartiles. According 
to the ROC curve analysis, the diagnostic potential of 
LDH at the 25th and 75th quartiles indicated that this 
biomarker had fair-to-good potential in predicting perio- 
dontitis, with the 50th quartile showing excellent potential. 
Table 1: Enzyme activity of salivary lactate dehydrogenase and β-glucuronidase according to smoking and periodontal 
status (N = 200)















Non-smokers with no/mild gingivitis 285.34 ± 35.76 237.78 ± 32.46 30.29 ± 9.43 25.24 ± 6.32
Smokers with no/mild gingivitis 213.92 ± 34.70 178.26 ± 32.34 24.81 ± 7.19 20.67 ± 6.56
Non-smokers with chronic generalised periodontitis 1,075.88 ± 253.76 896.56 ± 264.14 91.76 ± 12.05 76.46 ± 10.43
Smokers with chronic generalised periodontitis 819.10 ± 315.59 682.58 ± 274.12 85.53 ± 13.21 71.27 ± 12.71
LDH = lactate dehydrogenase; SD = standard deviation; min = minute.
Table 2: Comparison of specific enzyme activity of lactate dehydrogenase and β-glucuronidase according to periodontal 
status (N = 200)
Enzyme Mean specific activity in nmol/min/mg of total protein ± SD P value*
No/mild gingivitis Chronic generalised periodontitis
LDH 208.02 ± 22.95 789.57 ± 73.87 <0.001
β-glucuronidase 32.4 ± 6.44 269.13 ± 11.57 <0.001
min = minute; SD = standard deviation; LDH = lactate dehydrogenase. 
*Using an independent t-test.
Table 3: Comparison of specific enzyme activity of lactase dehydrogenase and β-glucuronidase according to smoking 
and periodontal status (N = 200)













LDH 237.78 ± 32.46 178.26 ± 32.34 896.56 ± 264.14 682.58 ± 274.12 <0.001 4>3>1>2
β-glucuronidase 25.24 ± 6.23 20.67 ± 6.56 76.46 ± 10.43 71.27 ± 12.71 <0.001 4>3>1>2
min = minute; SD = standard deviation; LDH = lactate dehydrogenase. 
*Using a one-way analysis of variance.
Table 4: Logistic regression model of lactate dehydrogenase 
and β-glucuronidase as possible predictors of periodontitis 
among smokers and non-smokers (N = 200)














Constant −19.35 6.746 8.227 - 0.004
SE = standard error; OR = odds ratio; CI = confidence interval; LDH = 
lactate dehydrogenase.
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For β-glucuronidase, the 25th and 50th percentiles indic- 
ated excellent predictive potential, while the 75th perc-
entile indicated fair potential [Table 5].
Discussion
The pathogenesis of tissue destruction in periodontitis 
is due to host-bacteria interactions which cause the host 
cells (mainly polymorphonuclear leukocyte lysosomes) 
to release granular enzymes which are capable of invading 
extracellular matrix components.17 Thus, the extra-
cellular presence of certain enzymes seems to play an 
important role in connective tissue damage. The quant- 
ification of enzyme activity in saliva, such as LDH 
and β-glucuronidase, can therefore provide important 
information and contribute to the timely diagnosis of 
periodontal disease.18 Combining these two markers 
into a risk profile for periodontal disease may offer 
improved accuracy in identifying susceptible patients.
In the current study, significantly higher LDH and 
β-glucuronidase activity was noted in the periodontitis 
groups compared to the non-periodontitis groups. How- 
ever, Lamster et al. observed variations in β-glucuron- 
idase enzyme activity among subjects with periodontitis.19 
This accentuates the fact that identical clinical cond-
itions may reflect different host responses. Therefore, 
while increased extracellular enzyme activity may have 
a positive correlation with disease activity, other factors 
could be involved in the aetiopathology of periodont-
itis.19 Such factors may also influence treatment planning. 
In the current study, relatively low enzyme activity 
was noted among smokers, including both those with 
no/mild gingival inflammation as well as those with 
chronic generalised periodontitis. Such findings are 
likely related to salivary changes resulting from exposure 
to inhaled cigarette smoke. Cigarette smoke contains 
over 4,000 chemicals as well as oxygen free radicals and 
volatile aldehydes that can cause damage to biomol-
ecules.20 Nagler et al. examined the effect of the in vitro
exposure of saliva to the gas phase of cigarette smoke; 
exposing saliva to cigarette smoke for three hours 
caused a 41% reduction in LDH activity.21 Furthermore, 
Avezov et al. reported a 34% reduction in LDH activity 
when salivary samples were exposed to different levels 
of cigarette smoke.22 
Nevertheless, although tobacco smoke significantly 
altered enzyme activity in the current study, these changes 
did not invalidate the predictive value of salivary LDH 
and β-glucuronidase as diagnostic biomarkers. Therefore, 
enzyme-based salivary diagnosis can be deemed an 
effective option in periodontitis cases, as influence of 
smoking on the biomarker status of LDH and β-glucuron- 
idase can be ruled out. With further studies, changes 
in enzyme activity may eventually form the basis of 
a convenient point-of-care diagnostic tool in routine 
oral health monitoring.
This study was subject to certain limitations. First, 
the analysis focused on the estimation of LDH and 
β-glucuronidase in the saliva rather than the gingival 
crevicular fluid, which would better reflect enzyme 
activity. Second, the methodology did not analyse the 
utility of these enzymes as markers of disease severity 
or response to treatment and, ultimately, disease progn- 
osis. Further studies are necessary to evaluate the reliab- 
ility of these parameters in this regard. Third, gender 
matching was not possible due to the unequal distrib-
ution of the sample. However, previous research has 
confirmed that gender does not significantly affect 
LDH levels, either among patients with periodontal 
disease or those with normal periodontia.23 Finally, the 
current study was designed with strict inclusion crit-
eria; thus, the exclusion of potential subjects may have 
hampered the generalisability of the results. 
Conclusion
The current study found that salivary LDH and β-glucu- 
ronidase enzyme activity significantly increased among 
patients with periodontal disease in comparison to those 
with no/mild gingival inflammation. While smoking 
significantly influenced enzyme activity, these changes 
were within acceptable limits and did not rule out the 
use of these enzymes as diagnostic biomarkers of perio- 
dontitis. However, further research is needed to identify 
other variables which may influence LDH and β-glucur- 
onidase enzyme activity.
Table 5: Sensitivity, specificity and area under receiver oper-
ating characteristic curve of salivary lactate dehydrogenase 
and β-glucuronidase alterations among periodontitis 












25th 206.75 63.3 90 0.774
50th 298.50 90 90 0.948
75th 841.50 100 66.7 0.819
β-glucuronidase
25th 21.95 98 98 0.980
50th 43.52 98 98 0.980
75th 72.35 100 66.7 0.750
ROC = receiver operating characteristic; LDH = lactate dehydrogenase. 
*The diagnostic accuracy of the enzymes was interpreted as follows: 1.0–0.91 = 
excellent; 0.90–0.81 = good; 0.80–0.71 = fair; 0.70–0.61 = poor; 0.60–0.51 = 
failure.
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